source
- STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and morePharma updates from the Pharmalot campus via the Pharmalittle newsletterSTAT · 2mo ago↗ source
- STAT+: Allogene CEO David Chang stepping downPfizer invests billions to buy Chinese drugs, WHO maps experimental response to Ebola outbreak, and other biotech news from The ReadoutSTAT · 2mo ago↗ source
- FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer DrugsThe U.S. Food and Drug Administration today issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs.fda press · 2mo ago